Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BLNE vs ACCL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACCL Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

ACCL Overall Winner 6-Pillar Tally: BLNE 2 – 4 ACCL Matrix Metrics: BLNE 3 – 7 ACCL

As of Nov 20, 2026, ACCL (ACCL) is the stronger overall head-to-head candidate over Beeline Holdings, Inc. (BLNE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). BLNE carries a Unified Composite Score of 43.4/100 (HOLD) at $0.29 (5.5x Forward P/E, -179.8% operating margin), whereas ACCL carries 64.5/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin).

  • Growth vs. Quality Trade-Off: ACCL earns the overall head-to-head edge with a stronger Unified Composite Score (64.5/100 BUY vs. BLNE 43.4/100 HOLD) and -0.16β · 56% Vol risk profile, whereas BLNE leads top-line expansion (+29.8% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: BLNE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 19.1); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BLNE vs ACCL
BLNE NASDAQ
Beeline Holdings, Inc. Common Stock
Mortgage Bankers & Loan Correspondents
$0.29
-21.72% 1D
Market Cap $13.1M
TTM Revenue $12M
Forward P/E 5.5x
Beta / 30D Vol 2.74β · 123% Vol
Unified Composite Score
43.4 / 100 HOLD
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.6%), weak momentum, RSI 19
RSI-14: 19.1 · SMA20: $0.57 · SMA50: $0.73
ACCL US Equity Head-to-Head Winner
ACCL
Institutional Equity
$2.36
-0.42% 1D
Market Cap $33.1M
TTM Revenue $5.2M
Forward P/E N/M
Beta / 30D Vol -0.16β · 56% Vol
Unified Composite Score
64.5 / 100 BUY
Tech 66.0 Fund 56.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 41
RSI-14: 40.8 · SMA20: $2.49 · SMA50: $2.62

6-Pillar Scorecard Institutional Category Breakdown (BLNE 2 – 4 ACCL)

Columns: Metric · BLNE · ACCL
1. Valuation Multiples BLNE
Forward P/E 5.5x N/M
Trailing P/E 5.5x 118.5x
PEG Ratio N/M N/M
EV / Revenue 2.5x 6.4x
2. Growth & Scale BLNE
Revenue Growth (YoY) +29.8% +11.3%
Earnings Growth (YoY) +0.0% -62.5%
TTM Revenue (USD) $12M $5.2M
Market Cap $13.1M $33.1M
3. Profitability & Quality ACCL
Gross Margin 100.0% 42.4%
Operating Margin -179.8% 4.5%
Net Profit Margin -185.9% 5.5%
Return on Equity (ROE) -42.4% 7.0%
4. Balance Sheet & Cash Flow ACCL
Cash Generation (TTM) -$24M $245,425 EBITDA
Cash Flow Margin N/A 4.7% EBITDA Mgn
Net Cash / Leverage $15M Net Debt (0.34x D/E) $0.43 Book/Sh · 7.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ACCL
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ACCL
OpEx & R&D Intensity N/A 37.9% of Rev ($2.0M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Mortgage Finance Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BLNE (3) vs ACCL (7)
Institutional Metric BLNE ACCL Criterion Row Edge
Market Capitalization
Scale
$13.1M $33.1M Larger Scale ACCL
Trailing P/E Ratio
Valuation
5.5x 118.5x Lower Multiple BLNE
Forward P/E Ratio
Valuation
5.5x N/M Lower Multiple BLNE
Revenue Growth (YoY)
Growth
+29.8% +11.3% Higher Growth BLNE
Operating Margin (TTM)
Profitability
-179.8% 4.5% Higher Margin ACCL
Net Profit Margin
Profitability
-185.9% 5.5% Higher Margin ACCL
Return on Equity (ROE)
Capital Efficiency
-42.4% 7.0% Higher ROE ACCL
52-Week Range Position
Momentum
0% ($0–$4) 30% ($1–$5) Stronger Trend ACCL
Beta / 30D Volatility
Risk Regime
2.74β · 123% Vol -0.16β · 56% Vol Lower Realized Risk ACCL
Unified Institutional Score
Composite Signal
43.4 / 100 (HOLD) 64.5 / 100 (BUY) Higher Composite ACCL
Trailing 12M Revenue (USD)
Operating Scale
$12M $5.2M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 42.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.5x EV/Rev N/M PEG · 6.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$24M ($15M Net Debt (0.34x D/E)) $245,425 EBITDA ($0.43 Book/Sh · 7.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACCL +46.19 pp
BLNE: -56.11% · ACCL: -9.92%
3M Horizon ACCL +52.14 pp
BLNE: -71.32% · ACCL: -19.18%
6M Horizon ACCL +143.55 pp
BLNE: -75.03% · ACCL: +68.52%
1Y Horizon ACCL +38.94 pp
BLNE: -80.81% · ACCL: -41.87%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BLNE vs ACCL. Trailing 12-month operating profitability (BLNE -179.8% vs ACCL 4.5%) and valuation multiples (BLNE 5.5x vs ACCL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BLNE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$12M
Gross Margin100.0%
Op. Margin-179.8%
ROE / Fwd P/E-42.4% · 5.5x
ACCL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.2M
Gross Margin42.4%
Op. Margin4.5%
ROE / Fwd P/E7.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BLNE BREAKDOWN
102d in phase · OBV DISTRIBUTION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact BLNE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACCL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACCL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BLNE Moat Profile Cyclical / Execution-Driven Positioning
Mortgage Finance Operator
Competes within the Mortgage Finance value chain with $13.1M market capitalization and -179.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ACCL Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $33.1M market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment 37.9% of Rev ($2.0M)
90D Engineering Disclosures 0 Published

Investor FAQ BLNE vs ACCL Key Questions & Quantitative Answers

As of Nov 20, 2026, ACCL (ACCL) is the stronger overall head-to-head candidate over Beeline Holdings, Inc. (BLNE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). BLNE carries a Unified Composite Score of 43.4/100 (HOLD) at $0.29 (5.5x Forward P/E, -179.8% operating margin), whereas ACCL carries 64.5/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin). Growth vs. Quality Trade-Off: ACCL earns the overall head-to-head edge with a stronger Unified Composite Score (64.5/100 BUY vs. BLNE 43.4/100 HOLD) and -0.16β · 56% Vol risk profile, whereas BLNE leads top-line expansion (+29.8% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: BLNE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 19.1); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BLNE leads the Growth & Scale pillar: BLNE posts +29.8% YoY revenue growth and +0.0% YoY earnings growth on $12M TTM revenue (100.0% gross margin, -179.8% operating margin), compared with ACCL at +11.3% YoY revenue growth and -62.5% YoY earnings growth on $5.2M TTM revenue (42.4% gross margin, 4.5% operating margin). On trailing 12-month operating scale, BLNE generates $12M in USD-normalized revenue versus $5.2M for ACCL. In operating R&D and SG&A reinvestment, BLNE deploys N/A (0 90-day corporate R&D disclosures) versus 37.9% of Rev ($2.0M) (0 disclosures) for ACCL.

BLNE screens cheaper on headline valuation multiples. BLNE trades at 5.5x Forward P/E, 5.5x Trailing P/E, N/M PEG, and 2.5x EV/Revenue (unreported FCF margin), whereas ACCL trades at N/M Forward P/E, 118.5x Trailing P/E, N/M PEG, and 6.4x EV/Revenue (4.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BLNE (-42.4% ROE) versus ACCL (7.0% ROE) capital efficiency.

In options market volatility and institutional positioning, BLNE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.74β · 123% Vol realized risk). By comparison, ACCL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.16β · 56% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.